Becomes the second drug in market to slow down the dreaded memory-loss disease; Will cost $32,000 for a 12-month treatment
Drugmaker
Latest in Drugmaker
acquisition
Pfizer expects to complete $43 billion acquisition of Seagen on Thursday
Acquisition is a key move for Pfizer after it saw a massive drop in revenue following the COVID-19 pandemic; Organisational changes initiated
Abu Dhabi
Meet the scientists using generative AI to cure cancer
With a mission to make longevity of human life possible, Insilico’s AI technology is making great strides in drug discovery to cure cancer
AI in healthcare
Pfizer extends its faith in CytoReason for AI-driven drug discovery
The partnership would be worth up to $110m over the next five years, including a $20 million equity investment in CytoReason’s computational models
Acino
ADQ to wholly acquire Swiss-based pharmaceutical company Acino
Acino works across more than 20 therapeutic areas including gastroenterology, cardiovascular and pain relief for high-quality pharmaceutical products in novel drug delivery forms
antibiotics drugs
Video: Why old drugs could fight Covid-19
A vaccine for the deadly coronavirus could be years away and the world can’t wait that long. But what if there was a cure that already existed? While big pharma races to make a new drug, some scientists are looking at what we already have on our shelves.
Alvotech
Dubai-based Cipla Gulf signs Icelandic partnership
Cipla Gulf is subsidiary of Indian pharma major Cipla,
British pharmaceutical company
UK pharma company GSK to begin production at UAE facility in 2020 – report
The company currently produces 80 percent of its products in the Gulf in Saudi Arabia.